Prediction of riboswitch as a potential drug target and design of its optimal inhibitors for Mycobacterium tuberculosis
by Somdutt Mujwar; Kamal Raj Pardasani
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 8, No. 4, 2015

Abstract: Non-homologous proteins have been widely identified as major drug targets in host-parasite diseases like tuberculosis. The available antibiotic treatment for infectious diseases have suffered a major setback due to the development of drug resistance by the pathogen. Therefore, in the present study the riboswitch is explored as a promising alternative potential drug target. A framework has been developed for the prediction of riboswitch as a potential drug target and design of corresponding inhibitor for M. tuberculosis bacteria by molecular docking simulation based virtual screening. The virtual screening is performed by using molecular library containing 5017 diverse ligands against tuberculosis bacterial riboswitch. Thus, it is concluded that the riboswitches can be alternative potential drug-target for infectious disease to overcome the present issues of existing antibiotic drugs like their side effects and drug resistance, etc. Further a single riboswitch can be a drug target for multiple strains of bacteria and other pathogenic organisms.

Online publication date: Tue, 15-Dec-2015

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com